Advanced biomed inc. announces launch of a+perfusc™ – integrated perfusion 3d cell culture platform for precision medicine and drug discovery

[tainan city], taiwan, sept. 19, 2025 (globe newswire) -- advanced biomed inc. (nasdaq: advb) (the “company”, “advanced biomed”), a biotechnology company focused on developing and commercializing innovative biomedical products for precision medicine and advanced diagnostics, today announced the launch of its a+perfusc™ system, a compact, all‑in‑one perfusion 3d cell culture incubator designed to replicate human physiological conditions in vitro.
ADVB Ratings Summary
ADVB Quant Ranking